Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
My-State Trek Virtual Event Provides New Opportunity to Support ALS Research While Social Distancing
Virtual event provides opportunities to get active at home and raise funds for cutting-edge ALS research at the ALS Therapy Development Institute (ALS TDI). - April 29, 2020 - ALS Therapy Development Institute
Virun and East West Bank Partner-Up to Save Lives
VIRUN Nutra-biosciences was able to get fully funded with the help of East West Bank. VIRUN manufactures food products and dietary supplements and are considered part of the essential workforce. Virun makes immune boosting products such as liposomal Vitamin C and patented, clinically proven Glutathione Tripeptides bound to Lactoferrin that have shown success in trials toward innate immunity. - April 22, 2020 - VIRUN
New Treatment Shows Vision Benefit in Age Related Macular Degeneration
MD Stem Cells reports results for Dry AMD from their clinical study SCOTS - the Stem Cell Ophthalmology Treatment Study. 63% of treated and evaluated eyes achieved improvement in vision while an additional 34% had vision remain stable in follow up. No complications occurred. Results were statistically significant. - April 18, 2020 - MD Stem Cells
Aciont's Paper, "Transscleral Iontophoresis for Noninvasive Ocular Drug Delivery of Macromolecules" Published in JOPT
Aciont Inc. announced today that results from preclinical studies of its Visulex-I technology is published online ahead of print in the Journal of Ocular Pharmacology and Therapeutics under the title “Transscleral Iontophoresis for Noninvasive Ocular Drug Delivery of... - April 18, 2020 - Aciont Inc.
Cellix Bio Pharma Initiates Acquisition of Avaca Pharma: Formulation Development CRO
Cellix Bio Pharma, a global contract research organization (CRO), transforms today’s healthcare challenges into tomorrow’s solutions. Cellix Bio Pharma is an experienced CRO focused on development of pharmaceutical formulations. Cellix Bio Pharma focuses to combine the AI computational power to the chemical and biological space in order to streamline drug discovery, design, development, and optimization that can expedite drug development. - April 10, 2020 - Cellix Bio Pharma Private Limited
National Medtech Society SWSNA Launches New Anthology of Home Health Tech Designed to Aid Distanced COVID-19 Patients Achieve Drug Free Relief
Shock Wave Society of North America (SWSNA) Announces New Anthology of Supplimental Home Health Devices launched this week in response to COVID-19 restrictive social distancing to compete with American’s barrier to clinic care. This new line of MedTech, called Oceanus PhysioLite, offers patients the personalized care they need from the safety of homes across the country. - March 29, 2020 - Shock Wave Society of North America
New Book is Now a Bestseller That Calls Attention to the False Premise of Traditional Science
A book released on March 1 entitled, “Is Science in Denial? Read This Book and Decide” has become the number one bestselling new release in the “Science and Math Quick Reads” category on Amazon. - March 18, 2020 - The Oaklea Press
Best Medical Website to be Named by Web Marketing Association in 24th Annual WebAward Competition
The Web Marketing Association is looking for the best medical websites in the world as part of their 24th annual international WebAward Competition for Web site development at www.webaward.org. The WebAwards is the standards-defining competition that sets benchmarks for 96 industries, including... - March 18, 2020 - Web Marketing Association
IVI Convenes First-of-its Kind Multi-Stakeholder Summit to Accelerate Aligning Value Assessment Methods with Real-World Decision Needs
Participants Define Consensus Expectations and Prioritize Research Agenda to Improve Value Assessment Methods - March 17, 2020 - Innovation and Value Initiative
Rare Diseases Research Funded by $220,000 in Grants from CABRI
In its ongoing commitment to funding research for new treatments for rare diseases, Cayman Biomedical Research Institute (CABRI) has announced its principle investigator and undergraduate awardees for the 2020 academic year. “We are excited to support these scientists actively researching... - March 12, 2020 - Cayman Chemical Company
Cincinnati-Based Health Network Partners with Medicom Health to Lower Out-of-Pocket Medication Expenses for Consumers
Electronic Medical Record Add-On Automates the Delivery of Rx Discounts at Enterprise Scale - March 10, 2020 - Medicom Health
Best Health Care Website to be Named by Web Marketing Association in 24th Annual WebAward Competition
Excellence deserves recognition and the Web Marketing Association is looking for the best healthcare websites in the world as part of their 24th annual international WebAward Competition. Healthcare related categories include healthcare, healthcare provider, medical, medical equipment, biotechnology and pharmaceutical websites. The deadline for Healthcare related websites to enter to be judged is May 29, 2020. - March 09, 2020 - Web Marketing Association
New Book Challenging Readers to Decide if Scientists Are in Denial Will be Free March 7 Though 11
Based on the fundamental principle of traditional science, consciousness and intelligence could not have existed until evolution produced a brain and cannot exist without one. A new book reveals credible evidence that indicates otherwise, suggesting western science needs to be updated. - March 07, 2020 - The Oaklea Press
Thrombolex Bashir® Endovascular Catheter First-In-Man (FIM) Trial for Acute Pulmonary Embolism
Thrombolex Bashir® Endovascular Catheter First-In-Man (FIM) Trial for Acute Pulmonary Embolism Confirms Early Safety and Feasibility and Impressive Reduction of Clot Burden - Results of FIM Trial presented at American Venous Forum (AVF) Annual Meeting - March 05, 2020 - Thrombolex, Inc.
Kirk McCarty Named President & CEO of Sky Ridge Medical Center
HealthONE announced today that Kirk McCarty, RN, MSN has been named the President and CEO of Sky Ridge Medical Center in Lone Tree, following the retirement announcement of Susan Hicks. McCarty has been promoted from his current role as Chief Operating Officer (COO) at Sky Ridge, a position he has... - February 29, 2020 - Sky Ridge Medical Center
Recombinetics Announces Collaboration with University of Texas Southwestern to Advance Regenerative Medicine Through Therapeutic Cell, Tissue, and Organ Production
Recombinetics (RCI) today announced a collaborative research project with University of Texas Southwestern (UTSW) to identify key factors that improve the efficiency of generating interspecies chimera between pigs and humans. This near-term goal will benefit the long-term objective of advancing... - February 27, 2020 - Recombinetics, Inc.
Bench International Places Dr. Scott Gottlieb, Former FDA Commissioner, as a Director with Illumina
Firm Launches Recruiting Hub in San Diego to Meet Talent Demands of Region’s Expanding Life Science Cluster - February 20, 2020 - Bench International
Thrombolex is Honored by Receiving Temple University’s Prestigious President’s Spin-Out Award
Temple University President, Richard Englert, and Vice President for Research, Michele Masucci, gathered colleagues to honor the University’s top inventors, and distinguished researchers at the third annual President’s Innovation Award Gala. Fueled by more than $279 million in annual... - February 19, 2020 - Thrombolex, Inc.
The University of British Columbia Botanical Garden and TEALEAVES Announce Their Attendance at the World Biodiversity Forum
At the inaugural World Biodiversity Forum in Davos, Switzerland in February, TEALEAVES and the University of British Columbia (UBC) Botanical Garden will facilitate a collaborative framework to preserve biodiversity through a network of international organizations. - February 14, 2020 - TEALEAVES
Nabil Adam Selected as Healthcare Co-Chair for the 2020 IEEE 6th World Forum on Internet of Things
Dr. Nabil Adam to Serve as Co-Chair of the Healthcare Track at Prestigious Institute of Electrical and Electronics Engineers Conference - February 12, 2020 - Nabil Adam
IVI Announces Six New Members to Board of Directors
IVI, the research-based non-profit organization improving the science and practice of value assessment, unveils six new members to its Board of Directors. - January 30, 2020 - Innovation and Value Initiative
MedBiome Licenses the RapidAIM Technology Targeting the Microbiome to Improve Human Health
MedBiome accelerates the development of drugs targeting the gut microbiome. The RapidAIM technology enables rapid screening of the effects of compounds on live individual human microbiomes in 96 well plates. - January 30, 2020 - MedBiome
ALS Therapy Development Institute Announces Naming of Augie’s Quest Translational Research Center
“It’s really incredible. For 15 years, Augie’s Quest has been dedicated to raising the critical funds and broad awareness needed to help fast-track ALS TDI’s cutting-edge ALS research – specifically providing ALS TDI with more than $150 million to advance its efforts to end ALS,” commented Steven Perrin Ph.D., CEO of ALS TDI. - January 24, 2020 - ALS Therapy Development Institute
Miss America to Speak at the 2020 National Conference and Trade Show of the National Drug and Alcohol Screening Association (NDASA)
Miss America 2020, Camille Schrier, will speak at the NDASA 2020 National Conference in Jacksonville, Florida March 9-11. - January 22, 2020 - National Drug and Alcohol Screening Association
John P. Butler, President and CEO of Akebia Therapeutics, Takes Helm as New Chair of Nation’s Largest Kidney Coalition
Butler will focus on supporting innovation to improve patient-centric care for individuals living with kidney disease, kidney failure and transplants. - January 21, 2020 - Kidney Care Partners
Milca Kaplan, CRNP, Located in Washington, DC, is Enhancing Her Practice by Partnering with Simpatra.Health
Milca Kaplan, CRNP will be adding Simpatra.Health’s BHRT services and technology to her practice. - January 13, 2020 - Simpatra
3Sixty Pharma Solutions Partners with Westchester Biotech Project
Leveraging its “360Start-Up” Powerhouse to Grow a Dynamic Non-Profit for Scientists - January 11, 2020 - 3Sixty Pharma Solutions
Michael Montesi, MD, Located in Cleveland, Mississippi, is Elevating His Practice by Partnering with Simpatra.Health
Michael Montesi, MD, will be adding Simpatra.Health’s BHRT services and technology to his practice. - January 10, 2020 - Simpatra
Co-Chair Invite Letter Released Ahead of SMi’s 4th Annual 3D Cell Culture Conference
SMi Reports: Co-chairs invite senior pharmaceutical professionals to join SMi's 3D Cell Culture Conference, taking place in February 2020 in London. - January 07, 2020 - SAE Media Group
GenInvo Launch
GenInvo launches to provide innovative and transformative solutions to the pharma industry to help bring life-changing treatments to patients faster. - December 23, 2019 - GenInvo, Inc.
New NF-kB Panel of Antibodies from AbboMax and Human Diseases
NF-kB is a protein complex that controls the transcription of DNA. It is a heterodimer sequestered in the cytoplasm. In response to activation NF-kB translocates to the nucleus to 'turn on' the expression of specific genes that keeps a cell proliferating and protects it from apoptosis. AbboMax has developed a panel of NF-kB related antibodies. - December 22, 2019 - AbboMax, Inc.
National Marrow Donor Program/Be The Match® Applauds Congress for Its Support of Patients with Blood Cancers and Other Diseases
Bipartisan legislation provides record funding for lifesaving cellular transplants and eliminates a Medicare payment barrier for seniors. - December 20, 2019 - National Marrow Donor Program
Eastern Biotech & Life Sciences Announces Expansion Plans Throughout the Gulf Region
Eastern Biotech & Life Sciences and Eastern Clinical Laboratories launch plans to extend their operations throughout The Middle East. - December 19, 2019 - Eastern Biotech & Life Sciences
ALS TDI Collaboration with Google’s Project Euphonia Highlighted in Documentary Series Featuring Former NFL Player Tim Shaw “The Age of A.I.” Hosted by Robert Downey Jr.
The ALS Therapy Development Institute (ALS TDI), the world’s foremost drug discovery lab focused solely on finding treatments and cures for ALS, today proudly announced that it is featured in episode two of “The Age of A.I.,” a new YouTube Originals documentary series that takes... - December 18, 2019 - ALS Therapy Development Institute
ALS Therapy Development Institute Reflects on the Impact of Pete Frates and the Ice Bucket Challenge
On Monday it was announced that Pete Frates passed away due to complications from ALS. Pete was a leader in the ALS community and the inspiration for the Ice Bucket Challenge, which helped raise millions of dollars for ALS research and awareness. Though it has been five years since the Challenge,... - December 11, 2019 - ALS Therapy Development Institute
Tigerlily Foundation Hosts Historic Young Women’s Metastatic Breast Cancer Disparities Fireside Chat at the San Antonio Breast Cancer Symposium
Tigerlily Foundation, a national breast cancer organization, will host a Young Women’s Metastatic Breast Cancer Disparities Fireside Chat at the 2019 San Antonio Breast Cancer Symposium (SABCS) on the morning of December 10. The event is designed to foster transformational dialogue engaging young women in the African American community from 20 cities identified as locations having a high rate of breast cancer diagnosis among women of color. - December 10, 2019 - Tigerlily Foundation
Virun® Making an Impact at PGA Show January 2020
Virun® will be amongst the 1,000+ interactive exhibitors attending the PGA Merchandise Show in Orlando, Florida January 21 through January 24. - December 06, 2019 - VIRUN
ALPCO Announces Deadline for Winter 2020 Diabetes Research Travel Grant Award
ALPCO announced the submission deadline for its Winter 2020 Diabetes Research Travel Grant Award. Each recipient is awarded up to $2500 to present their research at a relevant conference and a $2500 product credit. - December 04, 2019 - ALPCO
Equator Pure Nature CEO Peter Wainman Named “Expat Entrepreneur of the Year for Corporate Social Responsibility” in Thailand in 2019
Peter N. Wainman, the founder and CEO of Bangkok-based Equator Pure Nature Co., Ltd., was named the “Expat Entrepreneur of the Year for Corporate Social Responsibility” at the Thailand International Business Awards 2019. The award, presented in conjunction with the British Chamber of... - December 02, 2019 - Equator Pure Nature Co., Ltd.
CLL Society to Present Innovative Telemedicine Platform Study at American Society of Hematology Annual Conference
CLL Society co-founder and Medical Director Dr. Brian Koffman will present research results of the society's innovative telemedicine program at the prestigious American Society of Hematology annual meeting in early December. The program provides patients and caregivers access to HIPPA-compliant second opinions from renowned specialists in chronic lymphocytic leukemia (CLL), the most common adult blood cancer. - November 30, 2019 - CLL Society
Northern Optotronics Inc.'s New Dedicated Business Unit Helps U.S. and International Companies Resolve the Difficulty in Providing Repair Service Across Canada
Northern Optotronics Inc. (NOI), today announced the launch of its dedicated business unit focused on customized service and repair solutions across Canada for manufacturers and providers of medical equipment, aesthetic, surgical, and industrial lasers. - November 29, 2019 - NOI
JOGO Health to Launch 30 Digital Therapeutics Clinics in Malaysia to Treat Stroke, Pain and Incontinence
The clinics will use the award winning technology developed by two pioneering scientists in the USA that has also been shown to treat 17 other neuromuscular diseases. - November 28, 2019 - JOGO Health Inc.
New York Imaging Specialists Announces Grand Opening in Port Jefferson Station
New York Imaging Specialists announces the grand opening of its newest facility, at 1500 Route 112, Building 2A in Port Jefferson Station, NY 11776. New York Imaging Specialists features board-certified radiologists and the most modern imaging equipment. The ACR-accredited facility utilizes... - November 28, 2019 - New York Imaging Specialists
Dr. Varghese Cherian Joins New York Imaging Specialists
New York Imaging Specialists welcomes Varghese Cherian, MD, to its group of board-certified radiologists. Dr. Cherian will be practicing at New York Imaging Specialists’ newest facilities at 1500 Route 112, Building 2A in Port Jefferson Station and 640 County Road 39 in Southampton. Dr. - November 28, 2019 - New York Imaging Specialists
Good News: a Panel of TGF-Beta and TGF-Beta Receptor Antibodies is Created by Abbomax
TGF-β regulates multiple biological processes, including embryonic development, adult stem cell differentiation, proliferation, homeostasis, immune regulation, wound healing, and inflammation. Multiple cells synthesize TGF-β and many cells have specific receptors for this peptide. AbboMax created a panel of TGF-β and TGF-β receptors antibodies. AbboMax, Inc. has been developing & manufacturing antibodies, FFPE cell pellets slides, for many years in California. - November 23, 2019 - AbboMax, Inc.
Mavericks Renewable Energy and San Benito Hemp Campus Team Up to Create the First Carbon Negative Microgrid
San Benito Hemp Campus has over 300,000 square feet of seed production, secure storage, curing, processing and hemp facility in San Benito County, California. Opening in 2020, San Benito Hemp Campus will be the largest vertically integrated hemp processing facility in the United States. San Benito... - November 22, 2019 - Mavericks Renewable Energy
AT-1501, a Drug Discovered at the ALS Therapy Development Institute, Completes Phase I Trials
The ALS Therapy Development Institute (ALS TDI), a non-profit biotechnology company dedicated to the discovery and development of effective treatments for ALS, is pleased to share that AT-1501, a drug discovered and developed in the ALS TDI lab, has successfully completed Phase I clinical trials. - November 20, 2019 - ALS Therapy Development Institute
Nuriv® Delivers Impressive Lineup of Patented CBD Formulations
Nuriv® releases patented CBD formulations: RELAX, SLEEP, JOINT, along with its stand-alone CBD products, Hazelnut, Chocolate Brownie and French Vanilla. These release a powerfull Micellized form of CBD in amazing flavors, such as Peanut Butter Cup and Chocolate Brownie. Micellized compounds that are water insoluble absorb quicker, half speedy onset and improved Pharmacokinetics. 20mg CBD per 10ml serving and 22 servings per 8oz. - November 20, 2019 - VIRUN
Phase III Clinical Study of Valbenazine for Chorea in Huntington Disease
Huntington Study Group Announces Initiation of Phase III Clinical Study of Valbenazine for the Treatment of Chorea Associated with Huntington Disease. - November 14, 2019 - Huntington Study Group
SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020 – Speakers Announced
SMi Reports: the agenda and speaker overview of the upcoming SMi 22nd Annual Superbugs & Superdrugs Conference 2020, in London is now available to view. - November 07, 2019 - SAE Media Group